Data / Drug companies / Honour Lab Limited
Honour Lab Limited: 79 products in the FDA NDC directory, labeler code 69037
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Honour Lab Limited (labeler code 69037) lists 79 products in the FDA National Drug Code Directory. By type: 79 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on September 29, 2021.
The request: Watch Honour Lab Limited (FDA labeler code 69037): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 69037
- Products in commercial distribution
- 79
- Packages
- 79
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Controlled substance products
- Schedule IV 3, Schedule V 1
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- January 1, 1982
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 78 | 98.7% |
| Bulk ingredients for compounding | 1 | 1.3% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 79 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 78 | 98.7% |
| Injection, powder, for solution | 1 | 1.3% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Maralixibat chloride | 69037-0081 | Powder | Bulk ingredients | September 29, 2021 |
| Ubrogepant | 69037-0077 | Powder | Bulk ingredients | December 23, 2019 |
| Diroximel fumarate | 69037-0059 | Powder | Bulk ingredients | October 19, 2019 |
| Tafamidis meglumine | 69037-0065 | Powder | Bulk ingredients | May 3, 2019 |
| Ertugliflozin pidolate | 69037-0068 | Powder | Bulk ingredients | December 19, 2017 |
| Letermovir | 69037-0080 | Injection, powder, for solution | Bulk ingredients | November 8, 2017 |
| Edaravone | 69037-0060 | Powder | Bulk ingredients | May 5, 2017 |
| Vildagliptin | 69037-0028 | Powder | Bulk ingredients | January 1, 2017 |
| Sitagliptin phosphate | 69037-0022 | Powder | Bulk ingredients | December 31, 2016 |
| Sitagliptin hydrochloride | 69037-0021 | Powder | Bulk ingredients | December 31, 2016 |
| Posaconazole | 69037-0020 | Powder | Bulk ingredients | December 31, 2016 |
| Monomethyl fumarate | 69037-0018 | Powder | Bulk ingredients | December 31, 2016 |
| Crisaborole | 69037-0041 | Powder | Bulk ingredients | December 14, 2016 |
| Tenofovir alafenamide fumarate | 69037-0071 | Powder | Bulk ingredients | November 10, 2016 |
| Maraviroc | 69037-0062 | Powder | Bulk ingredients | November 4, 2016 |
| Maraviroc | 69037-0061 | Powder | Bulk ingredients | November 4, 2016 |
| Dolutegravir sodium | 69037-0044 | Powder | Bulk ingredients | June 9, 2016 |
| Brivaracetam | 69037-0055 | Powder | Bulk ingredients | May 12, 2016 |
| Selexipag amorphous | 69037-0036 | Powder | Bulk ingredients | December 21, 2015 |
| Sugammadex sodium | 69037-0050 | Powder | Bulk ingredients | December 15, 2015 |
| Aripiprazole lauroxil | 69037-0045 | Powder | Bulk ingredients | October 5, 2015 |
| Brexpiprazole | 69037-0035 | Powder | Bulk ingredients | July 10, 2015 |
| Sacubitril valsartan sodium hydrate | 69037-0082 | Powder | Bulk ingredients | July 7, 2015 |
| Sacubitril valsartan sodium on colloidal silicon dioxide | 69037-0043 | Powder | Bulk ingredients | July 7, 2015 |
| Sacubitril valsartan sodium hydrate | 69037-0040 | Powder | Bulk ingredients | July 7, 2015 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.